Skip to main content
XLO logo

XLO · Xilio Therapeutics, Inc. · Proposed Sales

Track XLO — free
$8.93 +0.00 (+0.00%) At close · Sep 11
Market Cap
$51.64M
Shares
5.78M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

No Proposed Sales

No Form 144 proposed-sale notices are available for this stock yet.

Key facts CIK 1840233 CUSIP 98422T209 13F (30d) 13 filings 13 filers Visit website Investor relations